Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers

24 Dec 2024

Abstract excerpt

Background: Psoriasis is a skin disease characterized by the presence of erythematous, scaly plaques on the extensor surfaces of the body. Treatment varies according to the stage of the disease, with the most severe cases being treated with biologic treatments that differ in efficacy and persistence over time. This study aimed to evaluate the 10-year persistence of biologic drugs (adalimumab, etanercept,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Health Systems, Economic Evaluations, Quality of Life
Share to Pharmaceutical studies and practices
Share to Psoriasis: Treatment and Pathogenesis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39857589
DOI: 10.3390/biomedicines13010005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic BiomarkersPMID 39857589Read ↗

Phenotypic differences and treatment persistence in a large multicentre cohort of axial psoriatic arthritis.Semantic proximity Read ↗

New-Onset Guttate Psoriasis: A Long-Term Follow-Up Study.Semantic proximity Read ↗

Long-term comparative analysis of secukinumab versus TNFα inhibitors in patients with spondyloarthritis: treatment persistence is differentially affected by disease phenotype, obesity and sex.Semantic proximity Read ↗

Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study.Semantic proximity Read ↗

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.Semantic proximity Read ↗

Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy.Semantic proximity Read ↗

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.Semantic proximity Read ↗

Establishing a Generalizable Early Improvement Cutoff in Psoriasis Area and Severity Index for Outcome Prediction Across Systemic TreatmentsSemantic proximity Read ↗

Biological Therapy Persistence in Severe Asthma: Real-World Evidence Beyond Fixed Follow-Up AnalysisSemantic proximity Read ↗

Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis.Semantic proximity Read ↗

Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.Semantic proximity Read ↗

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.